Humann Partners with UC Davis to Advance Cardiovascular Nutrition

The appointment of Dr. Schmitz, a former Chief Science Officer at Mars, Inc. and Senior Scholar at the UC Davis Graduate School of Management, signals a shift toward clinical validation for the supplement brand. Working alongside the Innovation Institute for Food and Health (IIFH), Schmitz will oversee the design of new studies and clinical trials aimed at decoding the intersection of dietary intake and cardiovascular markers.

CEO Joel Kocher describes the move as a departure from reactive healthcare, advocating for nutritional interventions that support the body before clinical issues emerge. By integrating the university's research capabilities, the company seeks to build on its existing portfolio of eight published clinical studies. Justin Siegel, faculty director at the IIFH, noted that the partnership utilizes advanced technology to bridge the gap between academic discovery and practical consumer applications, focusing on the broader goal of healthy aging for diverse populations.